These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 421995)

  • 1. Effects of spontaneous portal-systemic shunting on insulin metabolism.
    Smith-Laing G; Sherlock S; Faber OK
    Gastroenterology; 1979 Apr; 76(4):685-90. PubMed ID: 421995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
    Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
    Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma insulin and C-peptide levels in cirrhotic and uremic patients.
    Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y
    Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia in childhood cirrhosis.
    Gürsel T; Ozsoylu S; Bor N
    Helv Paediatr Acta; 1978 Dec; 33(6):527-34. PubMed ID: 738903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal systemic shunting of insulin does not lead to insulin resistance in patients with extrahepatic portal vein obstruction.
    Modi GK; Shah P; Acharya SK; Guleria R
    Horm Metab Res; 1999 Aug; 31(8):462-6. PubMed ID: 10494871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin and C-peptide in chronic liver diseases during oral glucose tolerance testing].
    Oehler G; Knecht M; Bleyl H; Matthes KJ
    Dtsch Med Wochenschr; 1984 Feb; 109(7):253-7. PubMed ID: 6365504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperinsulinemia in cirrhosis--increased secretion or impaired liver extraction?].
    Weber P; Martínek K
    Vnitr Lek; 1989 Aug; 35(8):802-8. PubMed ID: 2678734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
    Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
    Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bolus administration of obestatin does not change glucose and insulin levels neither in the systemic nor in the portal circulation of the rat.
    Kiewiet RM; Gauna C; van Aken MO; van de Zande B; van der Lely AJ
    Peptides; 2008 Dec; 29(12):2144-9. PubMed ID: 18930090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.
    Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Gonciarz M; Bielanski W; Reiter RJ; Konturek SJ
    J Pineal Res; 2009 May; 46(4):408-14. PubMed ID: 19552764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and experimental studies on elevated plasma level of insulin in cirrhotic patients with portal hypertension and portosystemic collateral circulation].
    Arakawa T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):468-81. PubMed ID: 6379413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
    Pelkonen R; Kallio H; Suoranta H; Karonen SL
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.